- Magellan Rx Management - https://www1.magellanrx.com -

Clinical Research

We are focused on harnessing the power of our valuable data and extensive clinical knowledge to bring the marketplace industry-leading research that can be a catalyst to improve health outcomes.

Asthma & Pulmonary
Behavioral Health
Cholesterol Management
Clinical Research
Cluster Headaches
Contraceptive Care
Digital Therapies
Heart Disease
Hepatitis C
Medication Therapy Management
Motivational Interviewing
Multiple Sclerosis
Neurological Conditions
Patient Engagement
Resident Research
The Emergence of Biosimilars for Oncology Treatment from a Payer’s Perspective
R. Borgert, M. Polson, K. Lawson, J. Rebello, H. Makanji
PCSK9-Inhibitor Persistence in a Medicare Population
M. Polson, J. Magness
Economic Model to Evaluate the Impact of Increased Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Rebates while also Reducing Prior Authorization Criteria
K. Prasla, T. Phelps
Reducing Rates of DPP-4i and GLP-1RA Co-Prescribing Using an Educational Letter Program
T. Williams, A. Johnson, A. Kangethe, S. Kim
An Impact Analysis Comparing Two Outreach Methods Informing Members of a Cost Savings Alternative in a Commercially Insured Diabetic Population
A. Pannier, M. Selden, A. Hanson
Predictability Between a Diagnosis of Systolic Heart Failure and Guideline Recommended Therapies in a Medicare Population Using Pharmacy Claims Data and ICD-10 Codes
A. Wilson, S. Spjut, J. Magness
Impact of a Pharmacist Driven Outreach Program
M. Selden, A. Hanson, A. Pannier
Impact of Sofosbuvir on Utilization and Expenditure of Hepatitis C Medications in a Medicaid Population
K. Prasla, C. Pigg
Medication Therapy Management: Outcomes of Telephonic Pharmacist Outreach
J. Magness
Physician Acceptance of Pharmacist Recommendations With and Without Cytochrome DNA Testing Among Medicare Patients
J. Magness
Acute Opioid Prescribing Patterns and Trends Related to Conversion of Chronic Opioid Use in a Medicare PDP Population
M. Polson, J. Magness
Retrospective Analysis of Claims Utilization Data of Medications Indicated to Treat Osteoporosis in the Medicare Part D Population
S. Spjut, J. Jarmoszko
Pharmacist Driven Shingrix Follow-Up, a Randomized Controlled Trial
S. Nestlehut, J. Magness
Outcomes of Health Plan-Initiated Text-Based Medication Refill Reminders in Medicare Patients
J. Magness
HIV Pre-Exposure Prophylaxis: Adherence, Retention, and Discontinuation Rates Between Single and Multiple Tablet Regimens
T. Williams
Rheumatoid Arthritis
Site of Service
Substance Abuse